Orthopedic Disorder
0
Pipeline Programs
3
Companies
4
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
StrykerCA - San Jose
2 programsBlueprint® Mixed Reality Pilot StudyN/A1 trial
Elbow Outcomes Clinical Study (WELBOW)N/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
StrykerBlueprint® Mixed Reality Pilot Study
StrykerElbow Outcomes Clinical Study (WELBOW)
BonesupportCERAMENT BVF
Utah MedicalpedCAT
Clinical Trials (4)
Total enrollment: 751 patients across 4 trials
Blueprint® Mixed Reality Pilot Study
Start: Feb 2024Est. completion: May 202544 patients
N/ACompleted
Elbow Outcomes Clinical Study (WELBOW)
Start: Jun 2020Est. completion: Sep 2024310 patients
N/ACompleted
CERAMENT™| Bone Void Filler Device Registry
Start: Mar 2020Est. completion: Mar 2028300 patients
N/ARecruiting
An Imaging Framework for Clinically Testing New Treatments to Prevent Post-traumatic OA
Start: Feb 2017Est. completion: Mar 202297 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 751 patients
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.